Last reviewed · How we verify

NCT02662322: KTHYPE

Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE)

Completed NA Last updated 7 May 2018
What this trial tests

NA trial testing Hypnotic communication in Anaesthesia in 294 participants. Completed in 6 September 2017.

Timeline
10 March 2016
Primary endpoint
6 March 2017
6 September 2017

Quick facts

Lead sponsorRennes University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment294
Start date10 March 2016
Primary completion6 March 2017
Estimated completion6 September 2017
Sites3 locations across Belgium, France

Drugs / interventions tested

Conditions studied

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Anaesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare three communications during peripheral intravenous catheterization and measure pain patient: one hypnotic, confusion (HYPNOSIS), an other with negative connotation (NOCEBO) and at least with neutral connotation (NEUTRAL).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Hypnosis and communication reduce pain and anxiety in peripheral intravenous cannulation: Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE), a multicentre randomised trial.
    Fusco N, Bernard F, Roelants F, Watremez C, et al · · 2020 · cited 22× · PMID 31862159 · DOI 10.1016/j.bja.2019.11.020

Verify or expand the search:

Other recruiting trials for Anaesthesia

Currently open trials in the same condition.

Other Rennes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02662322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing